Wiebke K Peitsch

7PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Traditional, complementary and integrative medicine not elsewhere classifiedRadiation therapyNonlinear optics and spectroscopyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 07, 2025
Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy.

Katharina Schumann, Kai Christian Klespe, Cornelia Mauch

|May 03, 2025
Low satisfaction with medical care among patients with hidradenitis suppurativa: A multicenter study.

Kerstin Wolk, Giorgia Cugno, Georgios Kokolakis

|Nov 12, 2024
Multiple linear papules in a 68-year-old man.

Paula Salchow, Emilia Mellerowicz, Lisa C Schneider

|Jun 26, 2024
Pseudoainhum and universal alopecia.

Lisa C Schneider, Alrun Hotz, Moritz Gugelmeier

|Nov 26, 2022
Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland.

Katharina Schumann, Cornelia Mauch, Kai-Christian Klespe

|Aug 25, 2022
Unique and common TCR repertoire features of Ni2+ -, Co2+ -, and Pd2+ -specific human CD154 + CD4+ T cells.

Franziska Riedel, Marina Aparicio-Soto, Caterina Curato

Pageof 2

Frequent Collaborators

2 joint publications

Reinhard Dummer

2 joint publications

Alexander Thiem

1 joint publications

Franziska Riedel

1 joint publications

Marina Aparicio-Soto